Determinant factors of leprosy-related disability; comparison of acceleration failure time and parametric shared frailty models

PLOS ONE RESEARCH ARTICLE Determinant factors of leprosy-related disability; comparison of acceleration failure time and parametric shared frailty models Bezanesh Melese Masresha ID1*, Kasim Mohammed Yesuf2, Yikeber Abebaw Moyehodie1, Hailegebrael Birhan Biresaw1, Solomon Sisay Mulugeta1, Gedam Derbew Addisia1 1 Debre Tabor University, Debre Tabor, Amhara, Ethiopia, 2 St. Paul’s Hospital Millennium Medical College School of Public Health, Addis Ababa, Ethiopia a1111111111 a1111111111 a1111111111 a1111111111 a1111111111 * Abstract Background OPEN ACCESS Citation: Masresha BM, Yesuf KM, Moyehodie YA, Biresaw HB, Mulugeta SS, Addisia GD (2023) Determinant factors of leprosy-related disability; comparison of acceleration failure time and parametric shared frailty models. PLoS ONE 18(4): e0271883. https://doi.org/10.1371/journal. pone.0271883 Editor: George Vousden, Public Library of Science, UNITED KINGDOM Received: March 12, 2021 Accepted: July 8, 2022 Published: April 3, 2023 Copyright: © 2023 Masresha et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Data Availability Statement: All relevant data are within the manuscript and its Supporting Information files. Funding: The authors received no specific funding for this work. Competing interests: The authors have declared that no competing interests exist. Abbreviations: AFT, Accelerated Failure Time; AHRI, Armauher Hansen Research Institute.; AIC, Leprosy is an illness persisting for a long time or constantly recurring brought about by Mycobacterium leprae. The collusion of the causing agent with Schwann cells leads to incapable of being changed loss of fringe nerve tissue; followed by incapacity and that is not restricted to actual powerlessness yet additionally makes a negative picture, prompting segregation and social disgrace against the altered people also, their families. Methods The analysis of this study comprises 205 samples of patients at All African TB and Leprosy Rehabilitation and Training Centre from January 2015 up to December 2019 G.C who were taking medication for leprosy and who possess all necessary data. Territorial conditions in the region of the patients were utilized as a clustering impact in all frailty models. Acceleration failure time models and parametric shared frailty models with Weibull and log-strategic patterns were utilized to dissect hazard factors related to disability ensued by leprosy. All fitted models were looked at by utilizing AIC. Results From that of 205, 69(33.7%) experienced at least one kind of disability grade during treatment taking. In light of AIC, log-logistic-gamma shared frailty model was the final best fitting model and also there was considerable variation among patients. The final model showed the age of patients, symptom duration, treatment category of patients, and sensory loss were found to be the most significant determinants of leprosy disability. Conclusion In this investigation, there is proof of heterogeneity at the group level and disability was related to the age of patients, symptom duration, treatment category of patient, what’s more, sensory loss subsequently, uncommon consideration ought to be given to these huge PLOS ONE | https://doi.org/10.1371/journal.pone.0271883 April 3, 2023 1 / 26 PLOS ONE Akaki Information Criterion; ALERT, All Africa Leprosy, Tuberculosis and Rehabilitation Training Centre; BC, Before Christ; DG, Disability Degree; ENAPAL, Ethiopian National Association of Peoples Affected by Leprosy; FMOH, Federal Ministry of Health; G0D, Grade Zero Disability; G1D, Grade One Disability; G2D, Grade Two Disability; GLRI, German Leprosy and TB Relief Association; HR, Hazard Ratio; ILEP, International Federation of AntiLeprosy Associations; LPAC, Leprosy Patients ALERT Center; LR, Likelihood Ratio; MB, Multibacillary; MDT, Multidrug therapy; PAL, Peoples Affected by Leprosy; PB, Pauci-bacillary; PPL, Penalized Partial Likelihood; SNNPR, Southern Nations, Nationalities, and Peoples’ Region; TB, Tuberculosis; WHO, World Health Organization. Determinant factors of leprosy related disability indicators, which eventually diminish the event of disability. To lessen the patient-related postponement, the program should lay more noteworthy accentuation on bringing issues to light in the local area by zeroing in on key messages like indications, inability result of the late discovery, accessibility of free treatment what’s more, accessibility of disease care in general wellbeing office. Introduction Leprosy is an illness persisting for a long time or constantly recurring brought about by Mycobacterium leprae. The causative agent affects peripheral nerves and causes damage by binding to Schwann cells which are important for conducting nerve impulses [1]. The interaction of M. leprae with Schwann cells causes irreversible loss of peripheral nerve tissue followed by disabilities. In some cases, nerve damage occurs without skin lesions which makes the diagnosis difficult leading to further damage. Leprosy is considered an important public health problem due to its morbidity and socioeconomic impact, both of which are consequences of complications (e.g., physical disability and deformities) that develop during the clinical outcome of the disease [2]. The damage is not limited to the physical inability but also creates a negative image leading to discrimination and social stigma against the affected individuals and their families [3]. Physical disability can occur before leprosy diagnosis, during treatment, and post-release from treatment [4]. About 15% of the world’s population has some form of disability [5]. The Global Leprosy scheme 2016–2020 spotlights early case recognition before apparent incapacities happen. Target recognition among higher danger bunches through leading efforts in profoundly endemic regions or networks; and further developing inclusion and access for underestimated populaces. This will bring about prior recognition and decrease of patients with gradeII disability (G2D) at the time of examination. The objective of G2D rate is less than one for every million populace [6]. According to the Global Leprosy (Hansen’s disease) Strategy 2021–2030 in the absence of verifiable data, it is estimated that 3–4 million people are living with visible impairments or deformities due to leprosy. Because both the label of leprosy and the disability it causes result in social exclusion in many communities, the number of people experiencing leprosy-related stigma is likely to be even greater [7]. According to official reports received from the World Health Organization, 214,783 new cases of leprosy were detected in 2016. India was one of the countries with the highest leprosy burden with more than 135,000 new leprosy patients being detected every ye (...truncated)